{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:21:10Z","timestamp":1791472870187,"version":"4.3.4"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,4,27]],"date-time":"2012-04-27T00:00:00Z","timestamp":1335484800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1471-2334-12-104","type":"journal-article","created":{"date-parts":[[2012,4,27]],"date-time":"2012-04-27T12:14:30Z","timestamp":1335528870000},"source":"Crossref","is-referenced-by-count":21,"title":["Empiric guideline-recommended weight-based vancomycin dosing and mortality in methicillin-resistant Staphylococcus aureus bacteremia: a retrospective cohort study"],"prefix":"10.1186","volume":"12","author":[{"suffix":"II","given":"Ronald G","family":"Hall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A","family":"Giuliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystal K","family":"Haase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen A","family":"Hazlewood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chistopher R","family":"Frei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas A","family":"Forcade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara D","family":"Brouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roger J","family":"Bedimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,4,27]]},"reference":[{"key":"2122_CR1","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/00007691-199410000-00013","volume":"16","author":"MP Ducharme","year":"1994","unstructured":"Ducharme MP, Slaughter RL, Edwards DJ: Vancomycin pharmacokinetics in a patient population: effect of age, gender, and body weight. Ther Drug Monit. 1994, 16: 513-518. 10.1097\/00007691-199410000-00013.","journal-title":"Ther Drug Monit"},{"key":"2122_CR2","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1128\/AAC.21.4.575","volume":"21","author":"RA Blouin","year":"1982","unstructured":"Blouin RA, Bauer LA, Miller DD, Record KE, Griffen WO: Vancomycin pharmacokinetics in normal and morbidly obese subjects. Antimicrob Agents Chemother. 1982, 21: 575-580. 10.1128\/AAC.21.4.575.","journal-title":"Antimicrob Agents Chemother"},{"key":"2122_CR3","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1007\/s002280050524","volume":"54","author":"LA Bauer","year":"1998","unstructured":"Bauer LA, Black DJ, Lill JS: Vancomycin dosing in morbidly obese patients. Eur J Clin Pharmacol. 1998, 54: 621-625. 10.1007\/s002280050524.","journal-title":"Eur J Clin Pharmacol"},{"key":"2122_CR4","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1128\/AAC.37.3.436","volume":"37","author":"K Vance-Bryan","year":"1993","unstructured":"Vance-Bryan K, Guay DR, Gilliland SS, Rodvold KA, Rotschafer JC: Effect of obesity on vancomycin pharmacokinetic parameters as determined by using a Bayesian forecasting technique. Antimicrob Agents Chemother. 1993, 37: 436-440. 10.1128\/AAC.37.3.436.","journal-title":"Antimicrob Agents Chemother"},{"key":"2122_CR5","first-page":"2004","volume-title":"Pocket Book of Infectious Disease Therapy","author":"B Bartlett","year":"2004","unstructured":"Bartlett B: Pocket Book of Infectious Disease Therapy. 2004, Philidelphia: Lippincott Williams & Wilkins, 2004-12","edition":"12"},{"key":"2122_CR6","volume-title":"The Sanford guide to antimicrobial therapy","author":"DN Gilbert","year":"2011","unstructured":"Gilbert DN, Moellering RC, Eliopoulos GM, Chambers HF, Saag MS: The Sanford guide to antimicrobial therapy. 2011, Sperryville, VA: Antimicrobial Therapy, Inc"},{"key":"2122_CR7","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2146\/ajhp080434","volume":"66","author":"M Rybak","year":"2009","unstructured":"Rybak M, Lomaestro B, Rotschafer JC, Moellering R, Craig W, Billeter M, Dalovisio JR, Levine DP: Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists. Am J Health Syst Pharm. 2009, 66: 82-98. 10.2146\/ajhp080434.","journal-title":"Am J Health Syst Pharm"},{"key":"2122_CR8","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron. 1976, 16: 31-41. 10.1159\/000180580.","journal-title":"Nephron"},{"key":"2122_CR9","doi-asserted-by":"publisher","first-page":"585","DOI":"10.7326\/0003-4819-115-8-585","volume":"115","author":"JW Chow","year":"1991","unstructured":"Chow JW, Fine MJ, Shlaes DM, Quinn JP, Hooper DC, Johnson MP, Ramphal R, Wagener MM, Miyashiro DK, Yu VL: Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med. 1991, 115: 585-590.","journal-title":"Ann Intern Med"},{"key":"2122_CR10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0924-8579(98)00060-0","volume":"11","author":"JW Chow","year":"1999","unstructured":"Chow JW, Yu VL: Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int J Antimicrob Agents. 1999, 11: 7-12. 10.1016\/S0924-8579(98)00060-0.","journal-title":"Int J Antimicrob Agents"},{"key":"2122_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4757-3027-2","volume-title":"Recursive partitioning in the health sciences","author":"H Zhang","year":"1999","unstructured":"Zhang H, Singer B: Recursive partitioning in the health sciences. 1999, New York: Springer"},{"key":"2122_CR12","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1097\/SHK.0b013e318182f98f","volume":"31","author":"JY Rhee","year":"2009","unstructured":"Rhee JY, Kwon KT, Ki HK, Shin SY, Jung DS, Chung DR, Ha BC, Peck KR, Song JH: Scoring systems for prediction of mortality in patients with intensive care unit-acquired sepsis: a comparison of the Pitt bacteremia score and the Acute Physiology and Chronic Health Evaluation II scoring systems. Shock. 2009, 31: 146-150. 10.1097\/SHK.0b013e318182f98f.","journal-title":"Shock"},{"key":"2122_CR13","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1001\/archinte.166.19.2138","volume":"166","author":"LK Hidayat","year":"2006","unstructured":"Hidayat LK, Hsu DI, Quist R, Shriner KA, Wong-Beringer A: High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. Arch Intern Med. 2006, 166: 2138-2144. 10.1001\/archinte.166.19.2138.","journal-title":"Arch Intern Med"},{"key":"2122_CR14","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1378\/chest.130.4.947","volume":"130","author":"MN Jeffres","year":"2006","unstructured":"Jeffres MN, Isakow W, Doherty JA, McKinnon PS, Ritchie DJ, Micek ST, Kollef MH: Predictors of Mortality for Methicillin-Resistant Staphylococcus aureus Health-Care-Associated Pneumonia: Specific Evaluation of Vancomycin Pharmacokinetic Indices. Chest. 2006, 130: 947-955. 10.1378\/chest.130.4.947.","journal-title":"Chest"},{"key":"2122_CR15","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ajic.2007.02.005","volume":"36","author":"FD Wang","year":"2008","unstructured":"Wang FD, Chen YY, Chen TL, Liu CY: Risk factors and mortality in patients with nosocomial Staphylococcus aureus bacteremia. Am J Infect Control. 2008, 36: 118-122. 10.1016\/j.ajic.2007.02.005.","journal-title":"Am J Infect Control"},{"key":"2122_CR16","doi-asserted-by":"publisher","first-page":"3315","DOI":"10.1128\/AAC.00113-08","volume":"52","author":"TP Lodise","year":"2008","unstructured":"Lodise TP, Graves J, Evans A, Graffunder E, Helmecke M, Lomaestro BM, Stellrecht K: Relationship between vancomycin MIC and failure among patients with methicillin-resistant Staphylococcus aureus bacteremia treated with vancomycin. Antimicrob Agents Chemother. 2008, 52: 3315-3320. 10.1128\/AAC.00113-08.","journal-title":"Antimicrob Agents Chemother"},{"key":"2122_CR17","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1093\/cid\/cir124","volume":"52","author":"R Kullar","year":"2011","unstructured":"Kullar R, Davis SL, Levine DP, Rybak MJ: Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets. Clin Infect Dis. 2011, 52: 975-981. 10.1093\/cid\/cir124.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-12-104\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-104","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-12-104.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T22:50:52Z","timestamp":1581979852000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-12-104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,27]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["2122"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-12-104","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,27]]},"article-number":"104"}}